NO882037L - Famotidin, polymerte former og fremstilling derav. - Google Patents

Famotidin, polymerte former og fremstilling derav.

Info

Publication number: NO882037L
Authority: NO; Norway
Prior art keywords: famotidine; manufacturing; polymeric forms; preparation; melting point
Prior art date: 1987-06-22

Application number

NO882037A

Other languages

English (en)

Other versions

NO882037D0 (no

Inventor

Montserrat Ballester-Rodes

Francisco Eugen Palomo-Nicolau

Antonio Luis Palomo-Coll

Original Assignee

Marga Para La Investigacion Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-22

Filing date

1988-05-10

Publication date

1988-12-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27240404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO882037(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-06-22 Priority claimed from ES8702020A external-priority patent/ES2009147A6/es

1987-10-29 Priority claimed from ES8703326A external-priority patent/ES2015339A6/es

1988-03-23 Priority claimed from ES8800888A external-priority patent/ES2017246A6/es

1988-05-10 Application filed by Marga Para La Investigacion Sa filed Critical Marga Para La Investigacion Sa

1988-05-10 Publication of NO882037D0 publication Critical patent/NO882037D0/no

1988-12-23 Publication of NO882037L publication Critical patent/NO882037L/no

Links

XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 title abstract 2
229960001596 famotidine Drugs 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
230000008018 melting Effects 0.000 abstract 2
238000002844 melting Methods 0.000 abstract 2
230000004071 biological effect Effects 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Steroid Compounds (AREA)
Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
Compositions Of Macromolecular Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Electron Beam Exposure (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicinal Preparation (AREA)
Pyridine Compounds (AREA)

NO882037A 1987-06-22 1988-05-10 Famotidin, polymerte former og fremstilling derav. NO882037L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ES8702020A ES2009147A6 (es)	1987-06-22	1987-06-22	Nuevo proceso para la preparacion de polimorfos de famotidina
ES8703326A ES2015339A6 (es)	1987-10-29	1987-10-29	Perfeccionamientos a la patente de invencion numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.
ES8800888A ES2017246A6 (es)	1988-03-23	1988-03-23	Mejoras a la patente de invencion, numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.

Publications (2)

Publication Number	Publication Date
NO882037D0 NO882037D0 (no)	1988-05-10
NO882037L true NO882037L (no)	1988-12-23

Family

ID=27240404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO882037A NO882037L (no)	1987-06-22	1988-05-10	Famotidin, polymerte former og fremstilling derav.

Country Status (13)

Country	Link
US (1)	US5021582A (no)
EP (1)	EP0297019B1 (no)
JP (1)	JPH01100162A (no)
KR (1)	KR920000308B1 (no)
CN (1)	CN1030077A (no)
AT (1)	ATE69052T1 (no)
AU (1)	AU1767288A (no)
CA (1)	CA1322760C (no)
DE (1)	DE3865899D1 (no)
DK (1)	DK342988A (no)
FI (1)	FI882329A7 (no)
IL (1)	IL86330A0 (no)
NO (1)	NO882037L (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU196775B (en) *	1986-08-05	1989-01-30	Richter Gedeon Vegyeszet	Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
WO1995001782A2 (en) *	1993-07-09	1995-01-19	R.P. Scherer Corporation	Method for making freeze dried drug dosage forms
CN1196730A (zh) *	1996-06-19	1998-10-21	雷迪博士研究基金会	具有增强的抗糖尿病活性的穴糖酮的新的多晶型形式及其制备方法
RU2192251C1 (ru) *	2001-05-25	2002-11-10	Дальневосточный государственный медицинский университет	Способ снижения гликемии у больных сахарным диабетом ii типа с гастродуоденальными язвами
JP4755789B2 (ja) *	2001-09-26	2011-08-24	株式会社フジシールインターナショナル	ラベル及びその製造方法
CA2426122A1 (en) *	2002-05-02	2003-11-02	M/S Tonira Pharma Limited	A process for the preparation of a combination of famotidine polymorphis a and b
US8058296B2 (en) *	2008-11-25	2011-11-15	Richard Tokunaga	Treatment and prevention of deleterious effects associated with alcohol consumption
CN117534630B (zh) *	2022-08-02	2025-11-18	重庆世森医药科技有限公司	一种高纯度法莫替丁精制得b晶型的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4496737A (en) *	1982-09-27	1985-01-29	Merck & Co., Inc.	Process for preparing sulfamylamidine antisecretory agents
JPS59227870A (ja) *	1983-06-07	1984-12-21	Yamanouchi Pharmaceut Co Ltd	新規２−グアニジノチアゾリン誘導体ならびにその製造法
HU194845B (en) *	1985-09-11	1988-03-28	Richter Gedeon Vegyeszet	Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
DE3644246A1 (de) *	1986-06-20	1987-12-23	Uriach & Cia Sa J	Verfahren zur herstelung von 3-(((2-((aminoiminomethyl)-amino)-4-thiazolyl)-methyl)-thio)-n-(aminosulfonyl)-propanimidamid
HU196775B (en) *	1986-08-05	1989-01-30	Richter Gedeon Vegyeszet	Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances

1988
- 1988-05-10 NO NO882037A patent/NO882037L/no unknown
- 1988-05-10 IL IL86330A patent/IL86330A0/xx unknown
- 1988-05-18 FI FI882329A patent/FI882329A7/fi not_active Application Discontinuation
- 1988-05-23 US US07/197,329 patent/US5021582A/en not_active Expired - Fee Related
- 1988-05-25 CN CN88103190A patent/CN1030077A/zh active Pending
- 1988-05-31 JP JP63134279A patent/JPH01100162A/ja active Pending
- 1988-06-01 EP EP88500054A patent/EP0297019B1/en not_active Expired - Lifetime
- 1988-06-01 DE DE8888500054T patent/DE3865899D1/de not_active Revoked
- 1988-06-01 AT AT88500054T patent/ATE69052T1/de not_active IP Right Cessation
- 1988-06-14 AU AU17672/88A patent/AU1767288A/en not_active Abandoned
- 1988-06-20 KR KR1019880007442A patent/KR920000308B1/ko not_active Expired
- 1988-06-21 CA CA000569954A patent/CA1322760C/en not_active Expired - Fee Related
- 1988-06-22 DK DK342988A patent/DK342988A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
JPH01100162A (ja)	1989-04-18
FI882329A0 (fi)	1988-05-18
IL86330A0 (en)	1988-11-15
DK342988A (da)	1988-12-23
EP0297019A1 (en)	1988-12-28
CN1030077A (zh)	1989-01-04
EP0297019B1 (en)	1991-10-30
CA1322760C (en)	1993-10-05
KR920000308B1 (ko)	1992-01-11
AU1767288A (en)	1988-12-22
ATE69052T1 (de)	1991-11-15
KR890000086A (ko)	1989-03-11
DE3865899D1 (de)	1991-12-05
NO882037D0 (no)	1988-05-10
US5021582A (en)	1991-06-04
DK342988D0 (da)	1988-06-22
FI882329A7 (fi)	1988-12-23

Similar Documents

Publication	Publication Date	Title
IT8819213A0 (it)	1988-01-26	Procedimento e dispositivo per la realizzazione di mescole di caucciu'.
IT8522494A0 (it)	1985-10-15	Procedimento per la preparazione di formulazioni solide di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute.
DK653688A (da)	1989-05-25	Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
DE3750431D1 (de)	1994-09-29	Stabilisiertes Arzneimittel und dessen Herstellung.
DE3883985D1 (de)	1993-10-14	Ärztliches instrument und dessen herstellung.
DK476885D0 (da)	1985-10-17	Heterocycliske forbindelser og fremgangsmaader til fremstilling heraf
IT8720650A0 (it)	1987-05-22	Derivati dell'etere immidazochinolinilico ad azione farmaceutica e procedimento per laloro preparazione.
FI913169A0 (fi)	1991-06-28	Oligonukleotidanaloger med terminala 3'-3'- eller 5'-5'-internukleotidkopplingar.
NO853466L (no)	1986-03-05	Stabilisert, smussfrigjoeringsbefordrende polymer av polyethylenterefthalat og polyoxethylenterefthalat og fremgangsmaate for fremstilling av denne.
LV10381A (lv)	1995-02-20	Cieto arstniecisko formu iegusanas panemiens un cietas arstnieciskas formas
NO882037D0 (no)	1988-05-10	Famotidin, polymerte former og fremstilling derav.
DE3778924D1 (de)	1992-06-17	Pyridazinon-derivate, deren herstellung und insektizide, akarizide, nematizide, fungizide zusammenstellungen.
DE3778089D1 (de)	1992-05-14	Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
BG45552A3 (bg)	1989-06-15	Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони
IT8667628A1 (it)	1988-02-04	Procedimento per la fabbricazione di strutture dicroiche d'antenna.
ATE100095T1 (de)	1994-01-15	2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
IT8984980A0 (it)	1989-09-21	Procedimento per la realizzazione di cingoli in gomma e cingolo cosi'.
NO881768D0 (no)	1988-04-22	Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
DE69021599D1 (de)	1995-09-21	Biologisch aktive RON-Substanz Synthetase und ihre Verwendung für die Herstellung biologisch aktiver RON-Substanz.
BG60271B1 (bg)	1994-03-31	13-алкил-23-имино и 13-хало-23-имино производни на ll-f28249 и приложението им като ендо- и ектопаразитицидни, инсектицидни, акарицидни и нематоцидни средства
DE3874422D1 (de)	1992-10-15	Feldeffekttransistor mit kurzer kanallaenge und verfahren zu dessen herstellung.
IT1232960B (it)	1992-03-11	Procedimento per la fabbricazione di nodo di struttura reticolare tubolare, e nodo cosi' ottenuto.
IT8722553A0 (it)	1987-11-06	Procedimento per la fabbricazione di corpi tubolari leggeri e corpo tubolare ottenuto tramite detto procedimento.
DE3888697D1 (de)	1994-04-28	2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
IT8723035A0 (it)	1987-12-16	Procedimento per la preparazione di n acilaniline.